Clinical Trial Update: A Study to Determine the Safety and the Efficacy of Fasinumab Compared to Placebo and Naproxen for Treatment of Adults With Pain From Osteoarthritis of the Knee or Hip [Phase 3]

View source ↗

Summary

Phase 3 trial assessing safety and efficacy of fasinumab versus placebo and naproxen for osteoarthritis of the knee or hip; study completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis of the Hip
• Osteoarthritis of the Knee

Drugs mentioned

• Fasinumab (fasinumab)
• Naproxen (Naproxen)

Snippet

Sponsor: Regeneron Pharmaceuticals | Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip | Phase 3 | Status: COMPLETED | Results posted: 2022-11-14